spacer
home > ict > spring 2008 > credible risk management
PUBLICATIONS

 

Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time. Sign up now!

       Already registered? Please sign in.

Alternatively, please use our pay-per-view service.

spacer

 
News and Press Releases

Nuvera PURE Reports name 2022 “best-in-class” pharmaceutical companies in oncology, neurology and immunology

[September 20, 2022] Nuvera Life Science Consulting, part of Ashfield Engage, is pleased to announce its second annual awards for the three pharmaceutical companies designated as “best-in-class” by physicians and support staff surveyed for the companies’ 2022 PURE Reports: AbbVie in immunology, AstraZeneca in oncology, and Biogen in neurology.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement